Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis

Rheumatology (United Kingdom)

Volumn 52, Issue 11, 2013, Pages 1941-1951

  McErlane, Flora ^a,b   Beresford, Michael W ^b,c   Baildam, Eileen M ^c   Thomson, Wendy ^a   Hyrich, Kimme L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Disease activity; Epidemiology; JADAS; Juvenile idiopathic arthritis; Outcome measures; Paediatric juvenile rheumatology; Standards of care

Indexed keywords

ACUTE PHASE PROTEIN;

CHILD PARENT RELATION; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); DEPRESSION; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE EXACERBATION; ERYTHROCYTE SEDIMENTATION RATE; FUNCTIONAL STATUS; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; OUTCOME ASSESSMENT; PARENT; PEDIATRICS; PRIORITY JOURNAL; REGISTER; REVIEW; RHEUMATOID ARTHRITIS; SELF EVALUATION; VALIDATION STUDY; WELLBEING;

DISEASE ACTIVITY; EPIDEMIOLOGY; JADAS; JUVENILE IDIOPATHIC ARTHRITIS; OUTCOME MEASURES; PAEDIATRIC/JUVENILE RHEUMATOLOGY; STANDARDS OF CARE;

ARTHRITIS, JUVENILE; DISABILITY EVALUATION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT OUTCOME ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 84886288485     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket150     Document Type: Review

References (58)

1. Symmons DP, Jones M, Osborne J et al. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol 1996;23:1975-80.
2. Petty RE, Southwood TR, Baum J et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998;25:1991-4.
3. Petty RE, Southwood TR, Manners P et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
4. Neogi T, Felson DT. Composite versus individual measures of disease activity in rheumatoid arthritis. J Rheumatol 2008;35:185-7.
5. Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005;23(5 Suppl 39):S100-8.
6. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52:3381-90.
7. Grigor C, Capell H, Stirling A et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263-9.
8. Verstappen SM, Jacobs JW, van dV et al. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:1443-9.
9. Beresford MW, Baildam EM. New advances in the management of juvenile idiopathic arthritis-2: the era of biologicals. Arch Dis Child Educ Pract Ed 2009;94:151-6.
10. Foster HE, Marshall N, Myers A et al. Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum 2003;48:767-75.
11. Minden K. Adult outcomes of patients with juvenile idiopathic arthritis. Horm Res 2009;72(Suppl 1):20-5.
12. Pelt PAv, Takken T, van Brussel M et al. Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA). Pediatr Rheumatol Online J 2012;10:27.
13. Ringold S, Wallace CA. Measuring clinical response and remission in juvenile idiopathic arthritis. Curr Opin Rheumatol 2007;19:471-6.
14. Giannini EH SC, Brewer EJ. Measuring grip strength in children with the Martin vigorimeter and adapted sphygmomanometer cuff. Occup Ther J Res 1984;4: 234-6.
15. Ruperto N, Giannini EH. Redundancy of conventional articular response variables used in juvenile chronic arthritis clinical trials. Ann Rheum Dis 1996;55:73-5.
16. Giannini EH, Ruperto N, Ravelli A et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
17. Brunner HI, Ravelli A. Developing outcome measures for paediatric rheumatic diseases. Best Pract Res Clin Rheumatol 2009;23:609-24.
18. Ruperto N, Ravelli A, Falcini F et al. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Ann Rheum Dis 1998;57:38-41.
19. Magni-Manzoni S, Cugno C, Pistorio A et al. Responsiveness of clinical measures to flare of disease activity in juvenile idiopathic arthritis. Clin Exp Rheumatol 2005;23:421-5.
20. Miller ML, Ruprecht J, Wang D et al. Physician assessment of disease activity in JIA subtypes. Analysis of data extracted from electronic medical records. Pediatr Rheumatol Online J 2011;9:9.
21. Lal SD, McDonagh J, Baildam E et al. Agreement between proxy and adolescent assessment of disability, pain, and well-being in juvenile idiopathic arthritis. J Pediatr 2011; 158:307-12.
22. Ravelli A, Viola S, Ruperto N et al. Correlation between conventional disease activity measures in juvenile chronic arthritis. Ann Rheum Dis 1997;56:197-200.
23. Hyrich KL, Lal SD, Foster HE et al. Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study. Rheumatology 2010;49:116-22.
24. Nugent J, Ruperto N, Grainger J et al. The British version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19(4 Suppl 23): S163-7.
25. Klepper SE. Measures of pediatric function: Child Health Assessment Questionnaire (C-HAQ), Juvenile Arthritis Functional Assessment Scale (JAFAS), Pediatric Outcomes Data Collection Instrument (PODCI), and Activities Scale for Kids (ASK). Arthritis Care Res 2011; 63(Suppl 11):S371-82.
26. Geerdink LM, Prince FH, Looman CW et al. Development of a digital Childhood Health Assessment Questionnaire for systematic monitoring of disease activity in daily practice. Rheumatology 2009;48:958-63.
27. Ravelli A, Viola S, Migliavacca D et al. Discordance between proxy-reported and observed assessment of functional ability of children with juvenile idiopathic arthritis. Rheumatology 2001;40:914-9.
28. Shaw KL, Southwood TR, McDonagh JE. Growing up and moving on in rheumatology: parents as proxies of adolescents with juvenile idiopathic arthritis. Arthritis Rheum 2006;55:189-98.
29. Palmisani E, Solari N, Magni-Manzoni S et al. Correlation between juvenile idiopathic arthritis activity and damage measures in early, advanced, and longstanding disease. Arthritis Rheum 2006;55:843-9.
30. Brunner HI, Lovell DJ, Finck BK et al. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol 2002;29:1058-64.
31. Lovell DJ, Ruperto N, Goodman S et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 2008;359:810-20.
32. Lovell DJ, Reiff A, Ilowite NT et al. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum 2008;58:1496-504.
33. Ruperto N, Lovell DJ, Quartier P et al. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet 2008;372:383-91.
34. Giannini EH, Lovell DJ, Silverman ED et al. Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group. J Rheumatol 1996;23:919-24.
35. Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31: 2290-4.
36. Wallace CA, Giannini EH, Huang B et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res 2011;63: 929-36.
37. Donnithorne KJ, Cron RQ, Beukelman T. Attainment of inactive disease status following initiation of TNF-alpha inhibitor therapy for juvenile idiopathic arthritis: enthesitisrelated arthritis predicts persistent active disease. J Rheumatol 2011;38:2675-81.
38. Ruperto N, Quartier P, Wulffraat N et al. A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. Arthritis Rheum 2012;64: 557-67.
39. Magni-Manzoni S, Ruperto N, Pistorio A et al. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. Arthritis Rheum 2008;59:1120-7.
40. Consolaro A, Vitale R, Pistorio A et al. Physicians' and parents' ratings of inactive disease are frequently discordant in juvenile idiopathic arthritis. J Rheumatol 2007; 34:1773-6.
41. Garcia-Munitis P, Bandeira M, Pistorio A et al. Level of agreement between children, parents, and physicians in rating pain intensity in juvenile idiopathic arthritis. Arthritis Rheum 2006;55:177-83.
42. Sztajnbok F, Coronel-Martinez DL, Diaz-Maldonado A et al. Discordance between physician's and parent's global assessments in juvenile idiopathic arthritis. Rheumatology 2007;46:141-5.
43. Consolaro A, Ruperto N, Bazso A et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 2009;61: 658-66.
44. Ringold S, Bittner R, Neogi T et al. Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticularcourse juvenile idiopathic arthritis: analysis of their ability to classify the American College of Rheumatology pediatric measures of response and the preliminary criteria for flare and inactive disease. Arthritis Care Res 2010;62: 1095-102.
45. Nordal EB, Zak M, Aalto K et al. Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting. Ann Rheum Dis 2012;71:1122-7.
46. McErlane F, Beresford MW, Baildam EM et al. Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis. Ann Rheum Dis 2012, Dec 20 [Epub ahead of print].
47. Consolaro A, Bracciolini G, Ruperto N et al. Remission, minimal disease activity and acceptable symptom state in juvenile idiopathic arthritis. Arthritis Rheum 2012;64: 2366-74.
48. Filocamo G, Consolaro A, Schiappapietra B et al. A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile Arthritis Multidimensional Assessment Report. J Rheumatol 2011;38:938-53.
49. Consolaro A, Ruperto N, Pistorio A et al. Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritis. Arthritis Care Res 2011;63:1262-70.
50. Tubach F, Ravaud P, Baron G et al. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis 2005;64:34-7.
51. Filocamo G, Consolaro A, Schiappapietra B et al. Parent and child acceptable symptom state in juvenile idiopathic arthritis. J Rheumatol 2012;39:856-63.
52. Heiberg T, Kvien TK, Mowinckel P et al. Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis. Ann Rheum Dis 2008;67967-71.
53. Haverman L, Grootenhuis MA, van den Berg JM et al. Predictors of health-related quality of life in children and adolescents with juvenile idiopathic arthritis: results from a Web-based survey. Arthritis Care Res 2012;64: 694-703.
54. Landgraf JM, Maunsell E, Speechley KN et al. Canadian-French, German and UK versions of the Child Health Questionnaire: methodology and preliminary item scaling results. Qual Life Res 1998;7:433-45.
55. Varni JW, Seid M, Smith Knight T et al. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. Arthritis Rheum 2002;46:714-25.
56. Duffy CM, Arsenault L, Duffy KN et al. The Juvenile Arthritis Quality of Life Questionnaire-development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides. J Rheumatol 1997;24: 738-46.
57. Carle AC, Dewitt EM, Seid M. Measures of health status and quality of life in juvenile rheumatoid arthritis: Pediatric Quality of Life Inventory (PedsQL) Rheumatology Module 3.0, Juvenile Arthritis Quality of Life Questionnaire (JAQQ), Paediatric Rheumatology Quality of Life Scale (PRQL), and Childhood Arthritis Health Profile (CAHP). Arthritis Care Res 2011; 63(Suppl 11):S438-45.
58. Haverman L, van Rossum MA, van Veenendaal M et al. Effectiveness of a web-based application to monitor health-related quality of life. Pediatrics 2013;131: e533-43.